Skip to Main Content

INFORMATION FOR

    Diseases of the Cardiovascular System, Phase II-III

    Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies (CRETE)

    What is the purpose of this trial?

    The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.

    • Trial with
      National Institutes of Health (NIH)
    • Ages
      17 years and younger
    • Gender
      Both

    Contact Information

    For more information about this study, including how to volunteer, contact Edward Vincent Faustino

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    • Last Updated
      10/03/2023
    • Study HIC
      #2000030683